#United States #Veeva Systems #Boston #Life Sciences #AI Strategies

Veeva Commercial Summit 2025: Fostering Unified Engagement in Life Sciences

The Veeva Commercial Summit, a significant annual gathering for life sciences professionals, is set to take place on May 13-14, 2025, in Boston. This year’s summit will showcase an impressive lineup of keynote speakers and industry leaders who will share transformative strategies aimed at enhancing customer engagement through advanced technology and strategic collaboration. With major companies like AstraZeneca, Bayer, and Eli Lilly set to present, attendees can expect insights that will shape the future of commercial engagement in the life sciences sector.

Keynote Highlights

Headlining the event will be Peter Gassner, the CEO of Veeva Systems. His opening keynote will focus on Veeva's groundbreaking initiative to enhance its Vault Platform with artificial intelligence capabilities. Gassner’s talk will highlight ongoing innovations within the Veeva Commercial Cloud and Veeva Data Cloud, aiming to demonstrate how AI can revolutionize customer interactions in the biopharmaceutical industry.

Other distinguished speakers will include representatives from top biopharmaceutical companies who will share their experiences and strategies:
- AstraZeneca will discuss how they are standardizing analytics across their various brands to amplify marketing performance.
- Bayer is expected to present on their efforts to drive coordinated customer engagement using the Vault CRM platform to better connect with clients.
- Boehringer Ingelheim plans to highlight how scientific insights can be leveraged in informing personalized conversations with key opinion leaders, creating deeper connections in the medical community.
- Eli Lilly will elaborate on their streamlined content ecosystem, showcasing how standardization and workflow integration have enabled them to deliver impactful experiences at scale.
- Johnson & Johnson and Madrigal Pharmaceuticals will present their innovative approaches to establishing modern data foundations aimed at enhancing operational efficiency and field effectiveness.

A Platform for Emerging Biotechs

The summit will also cater to emerging biopharmaceutical companies such as ANI Pharmaceuticals, Gamida Cell, and NewAmsterdam Pharma, who will share best practices for navigating the complexities of market launches and subsequent strategies to foster growth beyond initial product introductions. This emphasis on emerging companies reflects a commitment to inclusivity in the life sciences community, offering them a stage to share their insights and learn from more established players in the field.

Significance of Unified Engagement

As the integration of sales, marketing, and medical functions within organizations becomes increasingly critical, Matt Farrell, President of Veeva Commercial Cloud, emphasizes that unifying these aspects will allow teams to provide seamless, customer-centric experiences. This year’s summit aims to bring together industry professionals to brainstorm and collaborate on advances in AI and data-driven initiatives.

The Veeva Commercial Summit stands as one of the premier events for leaders in commercial and medical affairs across North America. Life sciences professionals interested in attending can register and view the full agenda at veeva.com/Summit.

About Veeva Systems

Veeva Systems is recognized as a global leader in cloud software tailored for the life sciences industry, committed to delivering innovative solutions and maintaining product excellence. Serving over 1,000 clients, from major biopharmaceutical corporations to newer biotech firms, Veeva balances the interests of all stakeholders, including employees, customers, and investors. As a Public Benefit Corporation, Veeva is dedicated to contributing positively to the industries it serves while striving for continuous improvement and satisfaction. For more information, visit veeva.com.

With the industry evolving rapidly, the insights and innovations shared at the Veeva Commercial Summit 2025 will undoubtedly play a crucial role in shaping the future of customer engagement in life sciences.